Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2

被引:30
作者
Bruhn, KW
Craft, N
Nguyen, BD
Yip, J
Miller, JF
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Specialty Training & Adv Res Program, Dept Med,Div Dermatol, Los Angeles, CA 90095 USA
关键词
Listeria monocytogenes; vaccination; tumor immunity;
D O I
10.1016/j.vaccine.2005.02.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A potential approach to activate tumor-specific T cells is to use live bacterial vectors to deliver appropriate antigens in a highly immunostimulatory context. We constructed a recombinant strain of Listeria monocytogenes (rLM) expressing murine tyrosinase-related protein-2 (TRP-2). a nonmutated melanocyte-derived differentiation antigen highly expressed in melanomas. Immunization of C57B1/6 mice with this rLM strain efficiently primed CD8 T cells to recognize the MHC class I-restricted TRP-2(180-188) epitope and express IFN-gamma upon in vitro peptide stimulation. Peptide-loaded target cells were lysed in vitro by TRP-2-specific T cells in cytotoxicity assays, and mice immunized and boosted with rLM expressing TRP-2 were functionally protected from subcutaneous challenge with B 16 melanoma cells. These results identify and characterize the anti-"self" T-cell responses induced by recombinant L. monocytogenes expressing an endogenous, nonmutated tumor antigen. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4263 / 4272
页数:10
相关论文
共 61 条
[1]   Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers:: a dose escalation study of oral inoculation [J].
Angelakopoulos, H ;
Loock, K ;
Sisul, DM ;
Jensen, ER ;
Miller, JF ;
Hohmann, EL .
INFECTION AND IMMUNITY, 2002, 70 (07) :3592-3601
[2]   INDUCTION OF IMMUNITY WITH AVIRULENT LISTERIA-MONOCYTOGENES 19113 DEPENDS ON BACTERIAL REPLICATION [J].
BALDRIDGE, JR ;
THOMASHOW, MF ;
HINRICHS, DJ .
INFECTION AND IMMUNITY, 1988, 56 (08) :2109-2113
[3]  
Barton GM, 2002, CURR TOP MICROBIOL, V270, P81
[4]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[5]   Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma [J].
Bloom, MB ;
PerryLalley, D ;
Robbins, PF ;
Li, Y ;
ElGamil, M ;
Rosenberg, SA ;
Yang, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :453-459
[6]   Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response [J].
Bouwer, HGA ;
Shen, H ;
Fan, X ;
Miller, JF ;
Barry, RA ;
Hinrichs, DJ .
INFECTION AND IMMUNITY, 1999, 67 (01) :253-258
[7]   Listeria-based cancer vaccines that segregate immunogenicity from toxicity [J].
Brockstedt, DG ;
Giedlin, MA ;
Leong, ML ;
Bahjat, KS ;
Gao, Y ;
Luckett, W ;
Liu, WQ ;
Cook, DN ;
Portnoy, DA ;
Dubensky, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) :13832-13837
[8]  
Chabalgoity Jose A, 2002, Expert Rev Vaccines, V1, P495, DOI 10.1586/14760584.1.4.495
[9]   Induction of immune responses by attenuated isogenic mutant strains of Listeria monocytogenes [J].
Darji, A ;
Mohamed, W ;
Domann, E ;
Chakraborty, T .
VACCINE, 2003, 21 :S102-S109
[10]   CD8+ T cell tolerance and cancer immunotherapy [J].
de Visser, KE ;
Schumacher, TNM ;
Kruisbeek, AM .
JOURNAL OF IMMUNOTHERAPY, 2003, 26 (01) :1-11